SE364037B - - Google Patents
Info
- Publication number
- SE364037B SE364037B SE11809/69A SE1180969A SE364037B SE 364037 B SE364037 B SE 364037B SE 11809/69 A SE11809/69 A SE 11809/69A SE 1180969 A SE1180969 A SE 1180969A SE 364037 B SE364037 B SE 364037B
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
- C07C53/136—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
- C07C53/138—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems containing an adamantane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/38—Acyl halides
- C07C53/44—Acyl halides containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/36—Acyl halides
- C07C55/38—Acyl halides containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pivots And Pivotal Connections (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB40968/68A GB1274652A (en) | 1968-08-27 | 1968-08-27 | Adamantanyl-alkylamine derivatives and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE364037B true SE364037B (de) | 1974-02-11 |
Family
ID=10417493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE11809/69A SE364037B (de) | 1968-08-27 | 1969-08-26 |
Country Status (12)
| Country | Link |
|---|---|
| JP (3) | JPS4939257B1 (de) |
| AT (1) | AT307380B (de) |
| BE (1) | BE737975A (de) |
| CH (3) | CH538442A (de) |
| DE (1) | DE1943404A1 (de) |
| DK (1) | DK131721C (de) |
| FR (1) | FR2016468B1 (de) |
| GB (1) | GB1274652A (de) |
| IE (1) | IE33929B1 (de) |
| IL (1) | IL32892A (de) |
| NL (1) | NL6913046A (de) |
| SE (1) | SE364037B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS507356A (de) * | 1973-05-22 | 1975-01-25 | ||
| GB0013737D0 (en) | 2000-06-07 | 2000-07-26 | Astrazeneca Ab | Novel compounds |
| SE0103836D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Novel compounds |
| SE0300480D0 (sv) | 2003-02-21 | 2003-02-21 | Astrazeneca Ab | Novel compounds |
| GB0312609D0 (en) | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| ITTO20030668A1 (it) * | 2003-09-02 | 2005-03-03 | Rotta Res Lab S P A O Ra Rottapharm | Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione. |
| WO2008114002A1 (en) | 2007-03-22 | 2008-09-25 | Astrazeneca Ab | Quinoline derivatives for the treatment of inflammatory diseases |
| US8106073B2 (en) | 2007-11-30 | 2012-01-31 | Astrazeneca Ab | Quinoline derivatives 057 |
| CN109593042B (zh) * | 2018-12-24 | 2021-12-07 | 陕西莱特迈思光电材料有限公司 | 一种有机电致发光材料及包含其的有机电致发光器件 |
| CN114181091B (zh) * | 2021-12-27 | 2024-06-14 | 维思普新材料（苏州）有限公司 | 一种金刚烷三苯胺的合成工艺 |
| CN116947644B (zh) * | 2023-07-26 | 2025-01-24 | 山东轩鸿生物医药有限公司 | 一种盐酸美金刚的制备方法 |
-
1968
- 1968-08-27 GB GB40968/68A patent/GB1274652A/en not_active Expired
-
1969
- 1969-08-25 IL IL6932892A patent/IL32892A/he unknown
- 1969-08-26 NL NL6913046A patent/NL6913046A/xx unknown
- 1969-08-26 CH CH1300669A patent/CH538442A/fr not_active IP Right Cessation
- 1969-08-26 AT AT817269A patent/AT307380B/de active
- 1969-08-26 BE BE737975A patent/BE737975A/xx unknown
- 1969-08-26 CH CH143372A patent/CH553149A/fr not_active IP Right Cessation
- 1969-08-26 DK DK457869A patent/DK131721C/da active
- 1969-08-26 DE DE19691943404 patent/DE1943404A1/de active Pending
- 1969-08-26 CH CH1435971A patent/CH551365A/fr not_active IP Right Cessation
- 1969-08-26 SE SE11809/69A patent/SE364037B/xx unknown
- 1969-08-27 IE IE1170/69A patent/IE33929B1/xx unknown
- 1969-08-27 FR FR696929356A patent/FR2016468B1/fr not_active Expired
-
1972
- 1972-06-29 JP JP47064563A patent/JPS4939257B1/ja active Pending
- 1972-06-29 JP JP47064562A patent/JPS4939256B1/ja active Pending
- 1972-06-29 JP JP47064561A patent/JPS5010856B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE33929B1 (en) | 1974-12-11 |
| AT307380B (de) | 1973-05-25 |
| JPS4939257B1 (de) | 1974-10-24 |
| IE33929L (en) | 1970-02-27 |
| CH551365A (fr) | 1974-07-15 |
| GB1274652A (en) | 1972-05-17 |
| FR2016468A1 (de) | 1970-05-08 |
| JPS5010856B1 (de) | 1975-04-24 |
| DK131721B (da) | 1975-08-25 |
| NL6913046A (de) | 1970-03-03 |
| BE737975A (de) | 1970-02-26 |
| IL32892A0 (en) | 1969-11-12 |
| CH538442A (fr) | 1973-06-30 |
| CH553149A (fr) | 1974-08-30 |
| DK131721C (da) | 1976-01-26 |
| FR2016468B1 (de) | 1973-06-08 |
| IL32892A (en) | 1975-04-25 |
| JPS4939256B1 (de) | 1974-10-24 |
| DE1943404A1 (de) | 1970-12-17 |